Blocking T helper 1/T helper 17 pathways has no effect on patch testing

Contact Dermatitis. 2013 Jan;68(1):58-9. doi: 10.1111/j.1600-0536.2012.02155.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Cross Reactions
  • Dermatitis, Allergic Contact / diagnosis
  • Dermatitis, Allergic Contact / etiology
  • Dermatitis, Allergic Contact / immunology*
  • Female
  • Histamine H1 Antagonists / adverse effects*
  • Histamine H1 Antagonists / immunology
  • Humans
  • Hydroxyzine / adverse effects*
  • Hydroxyzine / immunology
  • Middle Aged
  • Patch Tests*
  • Psoriasis / drug therapy
  • T-Lymphocytes, Helper-Inducer
  • Th1 Cells / drug effects*
  • Th17 Cells / drug effects*
  • Ustekinumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Histamine H1 Antagonists
  • Hydroxyzine
  • Ustekinumab